Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(100.0%)

6Total

N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05443698Not ApplicableCompleted

SELF-GYN1 (Sonograms Enable Looking Forward- Get Your iNformation 1 Trial)

Role: lead

NCT05509322Not ApplicableWithdrawn

Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial

Role: lead

NCT05282524Not ApplicableCompleted

Helping Adults Perform Transvaginal Exams Via Coaching at Home

Role: lead

NCT05004870Not ApplicableWithdrawn

Home Examinations Researching and Understanding Submucosal Evaluations

Role: lead

NCT04536545Completed

Evaluation of New Semen Collection & Transportation Kit

Role: lead

NCT04784325Not ApplicableCompleted

Anti-Mullerian Hormone - At My Home

Role: lead

NCT04687189Not ApplicableCompleted

Sonograms Enable Looking Forward - Home Examinations Led by Providers Validation Study

Role: lead

All 7 trials loaded